Company

Syndeio Biosciences

As of the edition of 20 October 2026, Syndeio Biosciences runs 3 drugs.

Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.

Drugs by status

StatusCount
Active2
Stopped1
Total3

Where its trials are

  • Mental health: 7 trials led
  • Nervous system: 1 trials led